Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32
United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026

What the insiders did No buying or selling

By person

10 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Brian Lian
President & CEO
—
—
—
2,572,441
$86.09M
+11.1%
Marianna Mancini
Chief Operating Officer
—
—
—
422,760
$14.15M
+13.2%
Greg Zante
Chief Financial Officer
—
—
—
212,204
$7.10M
+30.9%
Matthew W Foehr
Director
—
—
—
135,186
$4.52M
+21.5%
Lawson Macartney
Director
—
—
—
51,115
$1.71M
+6.6%
Charles A Rowland Jr
Director
—
—
—
33,150
$1.11M
+10.5%
J Matthew Singleton
Director
—
—
—
12,650
$423.33K
+33.2%
Dorothy Elizabeth Kelly-Gemmell
Director
—
—
—
6,333
$211.94K
—
Neil William Aubuchon
Chief Commercial Officer
—
—
—
4,475
$149.76K
—
Sarah Kathryn Rouan
Director
—
—
—
4,390
$146.91K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.